Skip to main content
Top
Published in: Journal of Medical Case Reports 1/2022

01-12-2022 | Stem Cell Transplantion | Case report

Large granular lymphocytic leukemia cured by allogeneic stem cell transplant: a case report

Authors: Edward Carey, Nicholas Ward, Maher Abdul-Hay

Published in: Journal of Medical Case Reports | Issue 1/2022

Login to get access

Abstract

Background

Large granular lymphocytic leukemia is a rare lymphocytic neoplasm that can pose a treatment challenge in patients with severe neutropenia in whom conventional therapies fail. We report one of the first cases in which allogeneic stem cell therapy was used as treatment for large granular lymphocytic leukemia.
We report and discuss the case of a 42-year-old white Caucasian female who, despite multiple therapies including methotrexate, cyclophosphamide, prednisone, cyclosporine, and pentostatin, continued to show severe neutropenia and recurrent infections. The patient was treated successfully and cured by allogeneic stem cell transplant without any major complications.

Conclusions

The significant importance of this case report is the introduction of a new treatment algorithm for challenging cases of T-cell large granular lymphocytic leukemia in which standard care fails. We hope that this case report will raise awareness of the potential benefits of allogeneic stem cell transplant in the treatment of aggressive forms of T-cell large granular lymphocytic leukemia.
Literature
1.
go back to reference Lamy T, Moignet A, Loughran TP Jr. LGL leukemia: from pathogenesis to treatment. Blood. 2017;129(9):1082–94.CrossRef Lamy T, Moignet A, Loughran TP Jr. LGL leukemia: from pathogenesis to treatment. Blood. 2017;129(9):1082–94.CrossRef
2.
go back to reference Shah MV, et al. A population-based study of large granular lymphocyte leukemia. Blood Cancer J. 2016;6(8): e455.CrossRef Shah MV, et al. A population-based study of large granular lymphocyte leukemia. Blood Cancer J. 2016;6(8): e455.CrossRef
3.
go back to reference Moignet A, Lamy T. Latest advances in the diagnosis and treatment of large granular lymphocytic leukemia. Am Soc Clin Oncol Educ Book. 2018;38:616–25.CrossRef Moignet A, Lamy T. Latest advances in the diagnosis and treatment of large granular lymphocytic leukemia. Am Soc Clin Oncol Educ Book. 2018;38:616–25.CrossRef
4.
go back to reference Zhang D, Loughran TP Jr. Large granular lymphocytic leukemia: molecular pathogenesis, clinical manifestations, and treatment. Hematology Am Soc Hematol Educ Program. 2012;2012(1):652–9. CrossRef Zhang D, Loughran TP Jr. Large granular lymphocytic leukemia: molecular pathogenesis, clinical manifestations, and treatment. Hematology Am Soc Hematol Educ Program. 2012;2012(1):652–9. CrossRef
5.
go back to reference Donato ML, et al. Treatment of T cell large granular lymphocyte leukemia with reduced-intensity allogeneic stem cell transplantation. Blood. 2007;110(11):4931–4931.CrossRef Donato ML, et al. Treatment of T cell large granular lymphocyte leukemia with reduced-intensity allogeneic stem cell transplantation. Blood. 2007;110(11):4931–4931.CrossRef
6.
go back to reference La Nasa G, et al. Allogeneic hematopoietic stem cell transplantation in a patient affected by large granular lymphocyte leukemia and multiple sclerosis. Ann Hematol. 2004;83(6):403–5.CrossRef La Nasa G, et al. Allogeneic hematopoietic stem cell transplantation in a patient affected by large granular lymphocyte leukemia and multiple sclerosis. Ann Hematol. 2004;83(6):403–5.CrossRef
7.
go back to reference DeZern AE, Sekeres MA. The challenging world of cytopenias: distinguishing myelodysplastic syndromes from other disorders of marrow failure. Oncologist. 2014;19(7):735–45.CrossRef DeZern AE, Sekeres MA. The challenging world of cytopenias: distinguishing myelodysplastic syndromes from other disorders of marrow failure. Oncologist. 2014;19(7):735–45.CrossRef
8.
go back to reference Marchand T, et al. Hematopoietic stem cell transplantation for T-cell large granular lymphocyte leukemia: a retrospective study of the European Society for Blood and Marrow Transplantation. Leukemia. 2016;30(5):1201–4.CrossRef Marchand T, et al. Hematopoietic stem cell transplantation for T-cell large granular lymphocyte leukemia: a retrospective study of the European Society for Blood and Marrow Transplantation. Leukemia. 2016;30(5):1201–4.CrossRef
9.
go back to reference Shah MV, Zhang R, Loughran TP Jr. Never say die: survival signaling in large granular lymphocyte leukemia. Clin Lymphoma Myeloma. 2009;9(Suppl 3):S244–53.CrossRef Shah MV, Zhang R, Loughran TP Jr. Never say die: survival signaling in large granular lymphocyte leukemia. Clin Lymphoma Myeloma. 2009;9(Suppl 3):S244–53.CrossRef
10.
go back to reference Watters RJ, Liu X, Loughran TP Jr. T-cell and natural killer-cell large granular lymphocyte leukemia neoplasias. Leuk Lymphoma. 2011;52(12):2217–25.CrossRef Watters RJ, Liu X, Loughran TP Jr. T-cell and natural killer-cell large granular lymphocyte leukemia neoplasias. Leuk Lymphoma. 2011;52(12):2217–25.CrossRef
11.
go back to reference Sokol L, Loughran TP Jr. Large granular lymphocyte leukemia. Oncologist. 2006;11(3):263–73.CrossRef Sokol L, Loughran TP Jr. Large granular lymphocyte leukemia. Oncologist. 2006;11(3):263–73.CrossRef
12.
go back to reference Alekshun TJ, Tao J, Sokol L. Aggressive T-cell large granular lymphocyte leukemia: a case report and review of the literature. Am J Hematol. 2007;82(6):481–5.CrossRef Alekshun TJ, Tao J, Sokol L. Aggressive T-cell large granular lymphocyte leukemia: a case report and review of the literature. Am J Hematol. 2007;82(6):481–5.CrossRef
13.
go back to reference Epling-Burnette PK, et al. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest. 2001;107(3):351–62.CrossRef Epling-Burnette PK, et al. Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. J Clin Invest. 2001;107(3):351–62.CrossRef
14.
go back to reference Jerez A, et al. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia. Blood. 2012;120(15):3048–57.CrossRef Jerez A, et al. STAT3 mutations unify the pathogenesis of chronic lymphoproliferative disorders of NK cells and T-cell large granular lymphocyte leukemia. Blood. 2012;120(15):3048–57.CrossRef
15.
go back to reference Gazitt T, Loughran TP Jr. Chronic neutropenia in LGL leukemia and rheumatoid arthritis. Hematology Am Soc Hematol Educ Program. 2017;2017(1):181–6.CrossRef Gazitt T, Loughran TP Jr. Chronic neutropenia in LGL leukemia and rheumatoid arthritis. Hematology Am Soc Hematol Educ Program. 2017;2017(1):181–6.CrossRef
16.
go back to reference Liu JH, Lamy T, Epling-Burnette PK, Starkebaum G, Djeu JY, Loughran TP. Chronic neutropenia mediated by Fas ligand. Blood. 2000;95(10):3219–22.CrossRef Liu JH, Lamy T, Epling-Burnette PK, Starkebaum G, Djeu JY, Loughran TP. Chronic neutropenia mediated by Fas ligand. Blood. 2000;95(10):3219–22.CrossRef
17.
go back to reference Dearden CE, et al. Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma). Br J Haematol. 2011;153(4):451–85.CrossRef Dearden CE, et al. Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma). Br J Haematol. 2011;153(4):451–85.CrossRef
18.
go back to reference Lamy T, Loughran TP Jr. How I treat LGL leukemia. Blood. 2011;117(10):2764–74.CrossRef Lamy T, Loughran TP Jr. How I treat LGL leukemia. Blood. 2011;117(10):2764–74.CrossRef
19.
go back to reference Bilori B, et al. Tofacitinib as a novel salvage therapy for refractory T-cell large granular lymphocytic leukemia. Leukemia. 2015;29(12):2427–9.CrossRef Bilori B, et al. Tofacitinib as a novel salvage therapy for refractory T-cell large granular lymphocytic leukemia. Leukemia. 2015;29(12):2427–9.CrossRef
20.
go back to reference Dumitriu B, et al. Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study. Lancet Haematol. 2016;3(1):e22–9.CrossRef Dumitriu B, et al. Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study. Lancet Haematol. 2016;3(1):e22–9.CrossRef
21.
go back to reference van der Zwan M, et al. Review of the clinical pharmacokinetics and pharmacodynamics of alemtuzumab and its use in kidney transplantation. Clin Pharmacokinet. 2018;57(2):191–207.CrossRef van der Zwan M, et al. Review of the clinical pharmacokinetics and pharmacodynamics of alemtuzumab and its use in kidney transplantation. Clin Pharmacokinet. 2018;57(2):191–207.CrossRef
22.
go back to reference Martin SI, et al. Infectious complications associated with alemtuzumab use for lymphoproliferative disorders. Clin Infect Dis. 2006;43(1):16–24.CrossRef Martin SI, et al. Infectious complications associated with alemtuzumab use for lymphoproliferative disorders. Clin Infect Dis. 2006;43(1):16–24.CrossRef
Metadata
Title
Large granular lymphocytic leukemia cured by allogeneic stem cell transplant: a case report
Authors
Edward Carey
Nicholas Ward
Maher Abdul-Hay
Publication date
01-12-2022

Other articles of this Issue 1/2022

Journal of Medical Case Reports 1/2022 Go to the issue